oa Opsoclonus Myoclonus Syndrome A Case Report of Two Patients and Review of the Literature

References

1. Boltshauser E, Deonna T, Hirt HR. Myoclonic encephalopathy of infa“nr dancing eyes syndrome:” report of 7 cases with long-term follow-up and review of the literature (cases with and without neuroblastoma). Helv Paediatr Acta. 1979; 34::119–113.
   [Google Scholar]
2. Solomon GE. Chutorian. Opsoclonus and occult neuroblastoma. N Engl J Med. 1968; 279::475–477.
   [Google Scholar]
3. Woods WG, Tuchman M. Neuroblastoma: The case for screening infants in North America. Pediatrics. 1987; 79::869–873.
   [Google Scholar]
4. Pochedly C, Strauss L. Histogenesis and pathology of neuroblastoma. Neuroblastoma. Acton MA: Publishing Sciences 1976;:155–179.
5. Altman AJ, Baehner RL. Favorable prognosis for survival in children with coincident op so-myoclonus and neuroblastoma. Cancer. 1976; 37::846–852.
   [Google Scholar]
6. Chiba S, Motoya H, Shinoda M, Nakao T. Myoclonic encephalopathy of infants: a report of two cases of dancing eyes syndrome. Dev Med Child Neurol. 1970; 12::767–771.
   [Google Scholar]
7. Sandok BA, Kranz H. Opsoclonus as the initial manifestation of occult neuroblastoma. Arch Ophthalmol. 1971; 86::235–236.
   [Google Scholar]
8. Glaser JS. Neurophthalmology. Philadelphia: JB Lippincott 1990:p.349.
   [Google Scholar]
9. Dyken P, Kolar O. Dancing eyes, dancing feet: infantile polymyoclonus. Brain. 1968; 91::305–320.
   [Google Scholar]
10. Christoff N. Myoclonic encephalopathy of infants: a report of two cases and observations on related disorders. Arch Neurol. 1969; 21::229–346.
    [Google Scholar]
11. Pranzatelli MR. The immunopharmacology of the opsoclonusmyoclonus syndrome. Clin Neuropharmacol. 1996; 19::1–47.
    [Google Scholar]
12. Senelick RC, Bray PF, Lahey E, Van Dyk HJL, Johnson DG. Neuroblastoma and myoclonic encephalopathy: two cases and a review of the literature. J Pediatr Surg. 1973; 8::623–632.
    [Google Scholar]
13. Kuban KC, Ephros MA, Freeman RL, Laffell LB, Bresnan MJ. Syndrome of opsoclonus-myoclonus caused by Coxsackie B3 infection. Ann Neurol. 1983; 13::69–71.
    [Google Scholar]
14. Mitchell WG, Snodgrass SR. Opsoclonus-ataxia due to childhood neural crest tumors: a chronic neurologic syndrome. J Child Neurol. 1990; 5::153–158.
    [Google Scholar]
15. Tuchman RF, Alvarez LA, Kantrowitz AB, Moser FG, Llena J, Moshe SL. Opsoclonus-myoclonus syndrome: correlation of radiographic and pathological observations. Neuroradiology. 1989; 31::250–252.
    [Google Scholar]
16. Parisi MT, Hattner RS, Matthay KK, Berg BO, Sandler ED. Optimized diagnostic strategy for neuroblastoma in opsoclonus-myoclonus. J Nucl Med. 1993; 34::1922–1926.
    [Google Scholar]
17. Telander RL, Smithson WA, Grover RV. Clinical outcome in children with acute cerebellar encephalopathy and neuroblastoma. J Pediatr Surgery. 1989; 24::11–14.
    [Google Scholar]
18. Ranzatelli MR. On the molecular mechanism of adrenocorticotrophic hormone in the CNS: neurotransmitters and receptors. Exp Neurol. 1994; 125::1–20.
    [Google Scholar]
19. Hammer MS. Lars en MB. Stack CV. Outcome of children with opsoclonus-myoclonus regardless of etiology. Pediatr Neurol. 1995; 13::21–24.
    [Google Scholar]
20. Russo C, Cohn SL, Petruzzi MJ, DeAlarcon PA. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group. Med Pediatr Oncol. 1997; 28::284–288.
    [Google Scholar]
21. Petruzzi MJ, De Alarcon PA. Neuroblastoma-associated opsoclonus-myoclonus treated with intravenously administered immune globulin G. J Pediatr. 1995; 127::328–329.
    [Google Scholar]
22. Sugie H, Sugie Y, Akimoto H, Endo K. High-dose human immunoglobulin in a case with infantile opsoclonus polymyoclonia syndrome. Acta Pediatrica. 1992; 81::371–372.
    [Google Scholar]